By: Dr. Mercola 16 October 2010 The Food and Drug Administration said preliminary results from a study in Mexico involving GlaxoSmithKline’s Rotarix vaccine suggest an increased risk of a serious bowel problem that could be fatal. A statement posted to the FDA’s website said the study showed an increased risk of intussusception in the 31-day […]
BARDA awards contracts for influenza vaccine
By: Paul Purlain 11 October 2010 The U.S. Department of Health and Human Services’ Biomedical Advanced Research Development Authority has announced a new contract worth $57 million to help safeguard the United States in the case of a pandemic influenza outbreak. The contract with French pharmaceutical company Sanofi Pasteur is an extension of an existing […]
FDA: Gardasil approved to prevent anal cancer
FDA Press Release 22 December 2010 The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years. Gardasil is already approved for the same age […]
Assessing the effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer: perspectives from Germany
By: Professor Martina Doren Originally published February 2010 For approximately 2 years now, cervical cancer has been “converted” from an oncological disease to an infectious disease, which is said to be preventable by and large by two vaccines licensed in many countries. However, human papillomavirus(HPV) vaccines differ from existing others, as the former target a […]
FDA Reviewers Endorse Gardasil for Anal Cancer Prevention
By: Emily P. Walker 15 November 2010 WASHINGTON — Merck’s quadrivalent human papillomavirus recombinant vaccine, Gardasil, appears safe and effective at preventing anal cancer in males and females ages 9 to 26, FDA reviewers said. The vaccine was approved in 2006 to treat genital warts and cervical, vulvar, and vaginal cancer in females ages 9 […]
